A comprehensive meta-analysis in depression and mortality, led by the Department of Psychiatry at the School of Clinical ...

Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have ...

A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...

When prescription depression drugs fall short in efficacy, there’s an off-label way to help them work better: add-on doses of thyroid hormone. Clinicians have long known about this approach and some ...

A clinical LSD formulation shows promise for severe anxiety. Trials reveal meaningful symptom relief and limited side effects ...

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

Nurse-led depression screening in long-term care can boost diagnosis and treatment rates for older adults, according to research presented at GAPNA 2025.